Medicines labeled for the same conditions
Alternatives to nepafenac
4 other medicines are given the same way (ophthalmic) and in the same FDA class as nepafenac or labeled mainly for the same use (pain); 3 are in its class, nonsteroidal anti-inflammatory drugs: ketorolac, bromfenac and diclofenac; the others include 1 corticosteroid (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $1.39 per mL (Ketorolac 0.5% eye solution) (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as nepafenac?
Pain lists all 80 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (ophthalmic) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Nepafenacnonsteroidal anti-inflammatory drug | this medicine | none listed | $121.14 per mL 0.3% eye drops | No | No current entry |
| Ketorolaccyclooxygenase inhibitor · same class | Pain | 17 labelers | $1.39 per mL 0.5% eye solution | Yes | In shortage |
| Bromfenacnonsteroidal anti-inflammatory drug · same class | Pain | 9 labelers | $13.25 per mL 0.07% eye drp | No | No current entry |
| Diclofenacnonsteroidal anti-inflammatory drug · same class | Pain | 5 labelers | $1.70 per mL 0.1% eye drops | Yes | A presentation being discontinued |
| Loteprednolcorticosteroid | Pain | 8 labelers | $10.47 per mL 0.5% drp | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Nepafenac: the full record
- label, generics, price, shortages, recalls